Get the Stockscreener App
0.4047
3.72%
0.0145
After Hours:
.40
-0.0047
-1.16%
Theriva Biologics Inc stock is traded at $0.4047, with a volume of 159.88K.
It is up +3.72% in the last 24 hours and down -0.57% over the past month.
Theriva Biologics, Inc., a clinical-stage company, develops therapeutics to treat diseases in areas of high unmet need. The company's lead product candidates include SYN-004 designed to degrade various commonly used intravenous beta-lactam antibiotics in gastrointestinal (GI) tract for the prevention of microbiome damage, clostridium difficile infection (CDI), overgrowth of pathogenic organisms, the emergence of antimicrobial resistance (AMR), and acute graft-versus-host-disease (aGVHD) in allogeneic hematopoietic cell transplant recipients; and SYN-020, a recombinant oral formulation for the enzyme intestinal alkaline phosphatase to treat both local GI and systemic diseases. It also develops VCN-01 for the treatment of patients with pancreatic cancer, head and neck squamous cell carcinoma, ovarian carcinoma, colorectal cancer, and retinoblastoma. In addition, the company develops clinical stage products, such as SYN-006 to prevent aGVHD and infection by carbapenem resistant enterococci; SYN-007 for preventing antibiotic associated diarrhea with oral ß-lactam antibiotics; SYN-005 for the prevention and treatment of pertussis; and VCN-11. It has collaborations with The University of Texas at Austin, and Cedars-Sinai Medical Center; and a clinical trial agreement with Washington University School of Medicine in St. Louis to conduct a Phase 1b/2a clinical trial of SYN-004. Theriva Biologics, Inc. is headquartered in Rockville, Maryland.
See More
Previous Close:
$0.3902
Open:
$0.39
24h Volume:
159.88K
Relative Volume:
0.28
Market Cap:
$3.88M
Revenue:
-
Net Income/Loss:
$-18.35M
P/E Ratio:
-0.3489
EPS:
-1.16
Net Cash Flow:
$-19.20M
1W Performance:
-1.29%
1M Performance:
-0.57%
6M Performance:
-70.02%
1Y Performance:
-87.43%
1-Day Range:
$0.3871
$0.408
1-Week Range:
$0.385
$0.4479
52-Week Range:
$0.3654
$4.97
Theriva Biologics Inc Stock (TOVX) Company Profile
Name
Theriva Biologics Inc
Sector
Industry
Phone
301 417 4364
Address
9605 Medical Center Drive, Suite 270, Rockville
Compare TOVX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TOVX
Theriva Biologics Inc
|
0.4047 | 3.75M | 0 | -18.35M | -19.20M | -1.16 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Theriva Biologics Inc Stock (TOVX) Latest News
Theriva Biologics Approves Key Proposals at Annual Meeting - MSN
market reaction to theriva biologics inc.’s recent news2025 Earnings Impact & Technical Entry and Exit Tips - Newser
Will Theriva Biologics Inc. bounce back from current supportBuy Signal & Low Drawdown Trading Strategies - Newser
Theriva Biologics Inc. stock trend forecastJobs Report & Community Consensus Trade Signals - Newser
Can technical indicators confirm Theriva Biologics Inc.’s reversal2025 Major Catalysts & Growth Focused Entry Reports - Newser
What’s the recovery path for long term holders of Theriva Biologics Inc.Market Growth Review & Step-by-Step Trade Execution Guides - Newser
Using fundamentals and technicals on Theriva Biologics Inc.July 2025 Highlights & Reliable Breakout Forecasts - Newser
How to read the order book for Theriva Biologics Inc.Market Weekly Review & Daily Entry Point Alerts - Newser
Can Theriva Biologics Inc. maintain sales growthWeekly Trend Summary & Fast Gain Swing Trade Alerts - 강소기업뉴스
Is Theriva Biologics Inc. benefiting from innovation trendsProduct Launch & Technical Confirmation Alerts - خودرو بانک
Will Theriva Biologics Inc. benefit from macro trendsMarket Rally & Real-Time Volume Analysis Alerts - Newser
Can Theriva Biologics Inc. expand its profit marginsChart Signals & Smart Investment Allocation Tips - خودرو بانک
Is Theriva Biologics Inc. currently under institutional pressure2025 Market WrapUp & Reliable Momentum Entry Alerts - خودرو بانک
Can Theriva Biologics Inc. deliver consistent dividendsPortfolio Return Report & High Conviction Investment Ideas - خودرو بانک
Can Theriva Biologics Inc. rally from current levels2025 Technical Overview & Stock Portfolio Risk Management - Newser
Predicting Theriva Biologics Inc. trend using moving averagesInsider Selling & Stepwise Trade Execution Plans - Newser
Is Theriva Biologics Inc. subject to activist investor interestIPO Watch & Growth Focused Stock Reports - خودرو بانک
Building trade automation scripts for Theriva Biologics Inc.July 2025 Patterns & Verified Chart Pattern Trade Signals - Newser
Will Theriva Biologics Inc. announce a stock splitTrade Volume Summary & Free Real-Time Volume Trigger Notifications - خودرو بانک
Is Theriva Biologics Inc. still worth holding after the dipWeekly Loss Report & Free Real-Time Market Sentiment Alerts - Newser
Can Theriva Biologics Inc. weather a recessionJuly 2025 Review & Growth Focused Stock Reports - خودرو بانک
Market reaction to Theriva Biologics Inc.’s recent newsJuly 2025 Intraday Action & Safe Entry Point Alerts - Newser
Does Theriva Biologics Inc. qualify in momentum factor screeningWeekly Trend Recap & Fast Entry Momentum Alerts - Newser
Aug Breakouts: Theriva Biologics Inc. Approaches Psychological Resistance LevelJuly 2025 Chart Watch & Safe Entry Point Alerts - beatles.ru
Risk vs reward if holding onto Theriva Biologics Inc.July 2025 Breakouts & AI Based Trade Execution Alerts - Newser
What is Theriva Biologics Inc. s debt to equity ratio2025 Buyback Activity & Long-Term Growth Portfolio Plans - خودرو بانک
What moving averages say about Theriva Biologics Inc.Rate Cut & Fast Entry Momentum Alerts - Newser
Activity Recap: Is Theriva Biologics Inc. benefiting from innovation trendsGap Up & Expert Curated Trade Ideas - خودرو بانک
Order flow analysis tools used on Theriva Biologics Inc.Rate Cut & Real-Time Volume Analysis - Newser
Is Theriva Biologics Inc. stock overvalued or fairly pricedJuly 2025 PreEarnings & AI Driven Stock Reports - خودرو بانک
Has Theriva Biologics Inc. found a price floorEarnings Performance Report & Technical Pattern Alert System - Newser
Using portfolio simulators with Theriva Biologics Inc. includedExit Point & AI Enhanced Trading Alerts - Newser
Advanced analytics toolkit walkthrough for Theriva Biologics Inc.2025 Winners & Losers & Precise Trade Entry Recommendations - Newser
Screener Results Flag Theriva Biologics Inc. as Oversold getLinesFromResByArray error: size == 0 - 강소기업뉴스
Comparing Theriva Biologics Inc. in custom built stock radarsJuly 2025 Opening Moves & Safe Entry Zone Tips - Newser
Volume spikes in Theriva Biologics Inc. stock – what they meanTrade Analysis Report & Long-Term Safe Investment Plans - Newser
Theriva Biologics Inc Stock (TOVX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.40%
Cap:
|
Volume (24h):